Medicare Part B Step Therapy Antimetabolites
Customize your policy alerts
Sign up for zing_health Policy 5892-D alerts
Get alerted when Policy 5892-D changes without checking for updates manually.
Monitor payer policy activity
This policy governs preferred and non-preferred antimetabolite products for Medicare Part B members requesting treatment. Non-preferred products require prior authorization and are covered when specified clinical exception criteria are met.
No material clinical or coverage changes in this revision.
Non-Preferred Product Exception Criteria
Non-preferred product exception criteria
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.